1. Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2023 Subject(s): Antibodies, MonoclonalCOVID-19 Drug TreatmentDrug ApprovalDrug IndustryGovernment RegulationLegislation, DrugSARS-CoV-2United States